Not applicableAvailableNCT05561985
What this trial is testing
Expanded Access Use of Itacitinib to Treat a Single Patient With STAT1 Gain of Function (GOF) Disease
Who this might be right for
STAT1 Gain-of-Function Disease
Incyte Corporation
Showing 13 of 13 results